Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000725058-08-000009
Filing Date
2008-03-14
Accepted
2008-03-14 17:11:51
Documents
9
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR FISCAL YEAR ENDED DECEMBER 31, 2007 form_10-k.htm 10-K 2550151
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM-KPMG exhibit_23-1.htm EX-23.1 5415
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM exhibit_23-2.htm EX-23.2 3122
4 CERTIFICATION-KEVIN G. LOKAY exhibit_31-1.htm EX-31.1 10568
5 CERTIFICATION-KEVIN J. BRATTON exhibit_31-2.htm EX-31.2 10545
6 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 exhibit_32-1.htm EX-32.1 6067
7 CERTIFICATION PURSUANT TO 18 U.S.C. SECITON 1350 exhibi_32-2.htm EX-32.2 5983
8 copyofcytogenlogopms.gif GRAPHIC 2030
9 form_10-k2.gif GRAPHIC 6306
  Complete submission text file 0000725058-08-000009.txt   2604992
Mailing Address 650 COLLEGE RD EAST STE 3100 PRINCETON NJ 08540
Business Address 650 COLLEGE RD EAST STE 3100 PRINCETON NJ 08540 6099878200
CYTOGEN CORP (Filer) CIK: 0000725058 (see all company filings)

EIN.: 222322400 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-14879 | Film No.: 08690308
SIC: 2834 Pharmaceutical Preparations